Economic Evaluation of Nutrition-Sensitive Agricultural Interventions to Increase Maternal and Child Dietary Diversity and Nutritional Status in Rural Odisha, India.

Cost–consequence analysis Dietary diversity India Maternal and child nutrition Nutrition-sensitive agriculture Participatory learning and action Women's groups

Journal

The Journal of nutrition
ISSN: 1541-6100
Titre abrégé: J Nutr
Pays: United States
ID NLM: 0404243

Informations de publication

Date de publication:
06 10 2022
Historique:
received: 25 08 2021
revised: 01 11 2021
accepted: 04 06 2022
pubmed: 11 6 2022
medline: 12 10 2022
entrez: 10 6 2022
Statut: ppublish

Résumé

Economic evaluations of nutrition-sensitive agriculture (NSA) interventions are scarce, limiting assessment of their potential affordability and scalability. We conducted cost-consequence analyses of 3 participatory video-based interventions of fortnightly women's group meetings using the following platforms: 1) NSA videos; 2) NSA and nutrition-specific videos; or 3) NSA videos with a nutrition-specific participatory learning and action (PLA) cycle. Interventions were tested in a 32-mo, 4-arm cluster-randomized controlled trial, Upscaling Participatory Action and Videos for Agriculture and Nutrition (UPAVAN) in the Keonjhar district, Odisha, India. Impacts were evaluated in children aged 0-23 mo and their mothers. We estimated program costs using data collected prospectively from expenditure records of implementing and technical partners and societal costs using expenditure assessment data collected from households with a child aged 0-23 mo and key informant interviews. Costs were adjusted for inflation, discounted, and converted to 2019 US$. Total program costs of each intervention ranged from US$272,121 to US$386,907. Program costs per pregnant woman or mother of a child aged 0-23 mo were US$62 for NSA videos, US$84 for NSA and nutrition-specific videos, and US$78 for NSA videos with PLA (societal costs: US$125, US$143, and US$122, respectively). Substantial shares of total costs were attributable to development and delivery of the videos and PLA (52-69%) and quality assurance (25-41%). Relative to control, minimum dietary diversity was higher in the children who underwent the interventions incorporating nutrition-specific videos and PLA (adjusted RRs: 1.19 and 1.27; 95% CIs: 1.03-1.37 and 1.11, 1.46, respectively). Relative to control, minimum dietary diversity in mothers was higher in those who underwent NSA video (1.21 [1.01, 1.45]) and NSA with PLA (1.30 [1.10, 1.53]) interventions. NSA videos with PLA can increase both maternal and child dietary diversity and have the lowest cost per unit increase in diet diversity. Building on investments made in developing UPAVAN, cost-efficiency at scale could be increased with less intensive monitoring, reduced startup costs, and integration within existing government programs. This trial was registered at clinicaltrials.gov as ISRCTN65922679.

Sections du résumé

BACKGROUND
Economic evaluations of nutrition-sensitive agriculture (NSA) interventions are scarce, limiting assessment of their potential affordability and scalability.
OBJECTIVES
We conducted cost-consequence analyses of 3 participatory video-based interventions of fortnightly women's group meetings using the following platforms: 1) NSA videos; 2) NSA and nutrition-specific videos; or 3) NSA videos with a nutrition-specific participatory learning and action (PLA) cycle.
METHODS
Interventions were tested in a 32-mo, 4-arm cluster-randomized controlled trial, Upscaling Participatory Action and Videos for Agriculture and Nutrition (UPAVAN) in the Keonjhar district, Odisha, India. Impacts were evaluated in children aged 0-23 mo and their mothers. We estimated program costs using data collected prospectively from expenditure records of implementing and technical partners and societal costs using expenditure assessment data collected from households with a child aged 0-23 mo and key informant interviews. Costs were adjusted for inflation, discounted, and converted to 2019 US$.
RESULTS
Total program costs of each intervention ranged from US$272,121 to US$386,907. Program costs per pregnant woman or mother of a child aged 0-23 mo were US$62 for NSA videos, US$84 for NSA and nutrition-specific videos, and US$78 for NSA videos with PLA (societal costs: US$125, US$143, and US$122, respectively). Substantial shares of total costs were attributable to development and delivery of the videos and PLA (52-69%) and quality assurance (25-41%). Relative to control, minimum dietary diversity was higher in the children who underwent the interventions incorporating nutrition-specific videos and PLA (adjusted RRs: 1.19 and 1.27; 95% CIs: 1.03-1.37 and 1.11, 1.46, respectively). Relative to control, minimum dietary diversity in mothers was higher in those who underwent NSA video (1.21 [1.01, 1.45]) and NSA with PLA (1.30 [1.10, 1.53]) interventions.
CONCLUSION
NSA videos with PLA can increase both maternal and child dietary diversity and have the lowest cost per unit increase in diet diversity. Building on investments made in developing UPAVAN, cost-efficiency at scale could be increased with less intensive monitoring, reduced startup costs, and integration within existing government programs. This trial was registered at clinicaltrials.gov as ISRCTN65922679.

Identifiants

pubmed: 35687367
pii: S0022-3166(23)08602-9
doi: 10.1093/jn/nxac132
pmc: PMC9535442
doi:
pii:

Substances chimiques

Polyesters 0

Banques de données

ISRCTN
['ISRCTN65922679']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2255-2268

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Références

Lancet. 2013 Aug 10;382(9891):536-51
pubmed: 23746780
Trials. 2018 Mar 9;19(1):176
pubmed: 29523173
Food Nutr Bull. 2021 Mar;42(1):3-22
pubmed: 33878905
Lancet Planet Health. 2021 May;5(5):e263-e276
pubmed: 33811818
Lancet. 2013 Aug 3;382(9890):452-477
pubmed: 23746776
PLoS One. 2016 Aug 18;11(8):e0160986
pubmed: 27536781
BMJ Glob Health. 2021 Nov;6(11):
pubmed: 34732513
BMC Public Health. 2019 Jul 18;19(1):961
pubmed: 31319837
Health Policy Plan. 2008 Nov;23(6):408-27
pubmed: 18755734
Value Health. 2013 Mar-Apr;16(2):231-50
pubmed: 23538175
Lancet Glob Health. 2017 Oct;5(10):e1004-e1016
pubmed: 28911749
J Nutr. 2020 Feb 1;150(2):350-355
pubmed: 31616933
Health Policy Plan. 2019 Nov 1;34(9):646-655
pubmed: 31504504
Nutr Rev. 2012 Dec;70(12):693-708
pubmed: 23206283
Cost Eff Resour Alloc. 2003 Feb 26;1(1):1
pubmed: 12773220
Glob Food Sec. 2021 Jun;29:100550
pubmed: 34164258
Cost Eff Resour Alloc. 2014 Apr 30;12:11
pubmed: 24834014
Matern Child Nutr. 2016 May;12 Suppl 1:169-85
pubmed: 27187914
J Nutr. 2018 Oct 1;148(10):1587-1597
pubmed: 30204916
Health Policy Plan. 2001 Mar;16(1):113-21
pubmed: 11238438
Health Policy Plan. 2005 Jul;20(4):252-9
pubmed: 15965037
Food Secur. 2022;14(1):67-80
pubmed: 35222745
Food Nutr Bull. 2019 Sep;40(3):393-408
pubmed: 31204503
Am J Agric Econ. 2018;100(3):906-930
pubmed: 32139914
PLoS One. 2016 Jan 04;11(1):e0145043
pubmed: 26727369
Eval Program Plann. 2016 Jun;56:11-22
pubmed: 27003730
Matern Child Nutr. 2016 May;12 Suppl 1:249-52
pubmed: 27187922
Wellcome Open Res. 2020 Apr 3;5:62
pubmed: 33102783
Trials. 2019 May 27;20(1):287
pubmed: 31133067
PLoS One. 2014 Mar 13;9(3):e91781
pubmed: 24626285
Health Policy Plan. 2021 May 17;36(4):533-541
pubmed: 33280036
BMC Health Serv Res. 2015 Dec 14;15:550
pubmed: 26652014
BMJ Glob Health. 2020 Jun;5(6):
pubmed: 32513863

Auteurs

Hassan Haghparast-Bidgoli (H)

University College London, Institute for Global Health, London, United Kingdom.

Helen Harris-Fry (H)

London School of Hygiene & Tropical Medicine, London, United Kingdom.

Abhinav Kumar (A)

Digital Green, New Delhi, India.

Ronali Pradhan (R)

Digital Green, New Delhi, India.

Naba Kishore Mishra (NK)

Voluntary Association for Rural Reconstruction and Appropriate Technology (VARRAT), Kendrapada, Odisha, India.

Shibananth Padhan (S)

Voluntary Association for Rural Reconstruction and Appropriate Technology (VARRAT), Kendrapada, Odisha, India.

Amit Kumar Ojha (AK)

Ekjut, Chakradharpur, Jharkhand, India.

Sailendra Narayan Mishra (SN)

Voluntary Association for Rural Reconstruction and Appropriate Technology (VARRAT), Kendrapada, Odisha, India.

Emily Fivian (E)

London School of Hygiene & Tropical Medicine, London, United Kingdom.

Philip James (P)

London School of Hygiene & Tropical Medicine, London, United Kingdom.

Sarah Ferguson (S)

Devoted Health, Waltham, MA, USA.

Sneha Krishnan (S)

Jindal School of Environment and Sustainability, OP Jindal Global University and ETCH Consultancy Services, Mumbai, Maharashtra, India.

Meghan O'Hearn (M)

Tufts University Friedman School of Nutrition Science and Policy, Boston, MA, USA.

Tom Palmer (T)

University College London, Institute for Global Health, London, United Kingdom.

Peggy Koniz-Booher (P)

SI Research & Training Institute, Inc. Arlington, VA, USA.

Heather Danton (H)

SI Research & Training Institute, Inc. Arlington, VA, USA.

Sandee Minovi (S)

SI Research & Training Institute, Inc. Arlington, VA, USA.

Satyanarayan Mohanty (S)

DCOR Consulting Pvt. Ltd. Bhubaneshwar, India.

Shibanand Rath (S)

Ekjut, Chakradharpur, Jharkhand, India.

Suchitra Rath (S)

Ekjut, Chakradharpur, Jharkhand, India.

Nirmala Nair (N)

Ekjut, Chakradharpur, Jharkhand, India.

Prasanta Tripathy (P)

Ekjut, Chakradharpur, Jharkhand, India.

Audrey Prost (A)

University College London, Institute for Global Health, London, United Kingdom.

Elizabeth Allen (E)

London School of Hygiene & Tropical Medicine, London, United Kingdom.

Jolene Skordis (J)

University College London, Institute for Global Health, London, United Kingdom.

Suneetha Kadiyala (S)

London School of Hygiene & Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH